A New Nucleosidyl-peptide Antibiotic, Sansanmycin

A New Nucleosidyl-peptide Antibiotic, Sansanmycin NRPS Substrate Promiscuity Leads to More Potent Antitubercular Sansanmycin Analogues NRPS Substrate Promiscuity Leads to More Potent Antitubercular Sansanmycin Analogues Rescrutiny of the sansanmycin biosynthetic gene cluster leads to the discovery of a novel sansanmycin analogue with more potency against Mycobacterium tuberculosis Rescrutiny of the sansanmycin biosynthetic gene cluster leads to the discovery of a novel sansanmycin analogue with more potency against Mycobacterium tuberculosis Napsamycins, new Pseudomonas active antibiotics of the mureidomycin family from Streptomyces sp. HIL Y-82, 11372. Improving the N-terminal diversity of sansanmycin through mutasynthesis Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives STUDIES ON TUBERACTINOMYCIN. II Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. II. Isolation and structural elucidation.